W2O Closes Investment Deal with New Mountain Capital
Update – In 2021, W2O became Real Chemistry. New Mountain Capital continues to partner with Real Chemistry to use AI and ideas to transform what healthcare is into what it should be.
Since partnering with New Mountain, Real Chemistry has acquired several companies that further enhance our role as the leading provide of AI-driven insights and human-centric experiences for the healthcare industry. Learn more about our acquisitions and partnership with New Mountain Capital below.
San Francisco, June 12, 2019 – W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, today announced that it has closed its previously announced investment partnership deal with New Mountain Capital.
“This partnership will allow us to achieve our mission of making the world a healthier place through marketing communications,” said Founder & CEO Jim Weiss. “We will invest to become the very best we can be, building our talent, technology and capabilities to serve our clients better and more expansively than ever – strategically, executionally, and geographically – all while maintaining our independent, entrepreneurial culture and spirit.”
About New Mountain Capital
New Mountain Capital is a New York-based investment firm that emphasizes business building and growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, public equity, and credit funds with over $20 billion in assets under management. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information on New Mountain Capital, please visit www.newmountaincapital.com.
